Therapeutic Asset Ratings
3,272 results matching 1 filter
91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Fexagratinib
Endometrial Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Fexagratinib
Carcinoma Of Esophagus
National Cancer Institute (NCI)
P2
CCC
(53)
Fexagratinib
Exocrine Pancreatic Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Fexagratinib
Gastric Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Fexagratinib
Head And Neck Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Fexagratinib
Renal Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Fexagratinib
Hepatocellular Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Fexagratinib
Lung Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Fexagratinib
Uterine Corpus Cancer
National Cancer Institute (NCI)
P2
CCC
(53)
Fexagratinib
Uterine Cancer
National Cancer Institute (NCI)
P2
CCC
(53)
Fexagratinib
Ovarian Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Fexagratinib
Prostate Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Fexagratinib
Rectal Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Fexagratinib
Skin Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Fexagratinib
Thyroid Gland Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Floxuridine
Adrenal Cortex Neoplasm
National Cancer Institute (NCI)
P2
CCC
(53)
Floxuridine
Adrenal Gland Cancer
National Cancer Institute (NCI)
P2
CCC
(53)
Floxuridine
Adrenal Gland Neoplasm
National Cancer Institute (NCI)
P2
CCC
(53)
Floxuridine
Adrenal Cortex Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Floxuridine
Bile Duct Cancer
National Cancer Institute (NCI)
P2
CCC
(53)
Floxuridine
Bile Duct Neoplasm
National Cancer Institute (NCI)
P2
CCC
(53)
Fludarabine
Duodenum Cancer
National Cancer Institute (NCI)
P2
CCC
(53)
Fludarabine
Malignant Endocrine Neoplasm
National Cancer Institute (NCI)
P2
CCC
(53)
Fludarabine
Digestive System Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
FLUDEOXYGLUCOSE
Anal Canal Squamous Cell Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Showing 1351 to 1375 of 3,272 assets
Previous
Page 55 of 131
Next